182 related articles for article (PubMed ID: 29054602)
21. A STAT1-gain-of-function mutation causing Th17 deficiency with chronic mucocutaneous candidiasis, psoriasiform hyperkeratosis and dermatophytosis.
Nielsen J; Kofod-Olsen E; Spaun E; Larsen CS; Christiansen M; Mogensen TH
BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26494717
[TBL] [Abstract][Full Text] [Related]
22. Autosomal-dominant chronic mucocutaneous candidiasis with STAT1-mutation can be complicated with chronic active hepatitis and hypothyroidism.
Hori T; Ohnishi H; Teramoto T; Tsubouchi K; Naiki T; Hirose Y; Ohara O; Seishima M; Kaneko H; Fukao T; Kondo N
J Clin Immunol; 2012 Dec; 32(6):1213-20. PubMed ID: 22847544
[TBL] [Abstract][Full Text] [Related]
23. Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation.
Bloomfield M; Kanderová V; Paračková Z; Vrabcová P; Svatoň M; Froňková E; Fejtková M; Zachová R; Rataj M; Zentsová I; Milota T; Klocperk A; Kalina T; Šedivá A
J Clin Immunol; 2018 Jul; 38(5):589-601. PubMed ID: 29934865
[TBL] [Abstract][Full Text] [Related]
24. New host defense mechanisms against Candida species clarify the basis of clinical phenotypes.
Hanna S; Etzioni A
J Allergy Clin Immunol; 2011 Jun; 127(6):1433-7. PubMed ID: 21497889
[TBL] [Abstract][Full Text] [Related]
25. The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1.
Depner M; Fuchs S; Raabe J; Frede N; Glocker C; Doffinger R; Gkrania-Klotsas E; Kumararatne D; Atkinson TP; Schroeder HW; Niehues T; Dückers G; Stray-Pedersen A; Baumann U; Schmidt R; Franco JL; Orrego J; Ben-Shoshan M; McCusker C; Jacob CM; Carneiro-Sampaio M; Devlin LA; Edgar JD; Henderson P; Russell RK; Skytte AB; Seneviratne SL; Wanders J; Stauss H; Meyts I; Moens L; Jesenak M; Kobbe R; Borte S; Borte M; Wright DA; Hagin D; Torgerson TR; Grimbacher B
J Clin Immunol; 2016 Jan; 36(1):73-84. PubMed ID: 26604104
[TBL] [Abstract][Full Text] [Related]
26. Human STAT1 gain-of-function iPSC line from a patient suffering from chronic mucocutaneous candidiasis.
Haake K; Wüstefeld T; Merkert S; Lüttge D; Göhring G; Auber B; Baumann U; Lachmann N
Stem Cell Res; 2020 Mar; 43():101713. PubMed ID: 32000109
[TBL] [Abstract][Full Text] [Related]
27. Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
Tabellini G; Vairo D; Scomodon O; Tamassia N; Ferraro RM; Patrizi O; Gasperini S; Soresina A; Giardino G; Pignata C; Lougaris V; Plebani A; Dotta L; Cassatella MA; Parolini S; Badolato R
J Allergy Clin Immunol; 2017 Aug; 140(2):553-564.e4. PubMed ID: 28069426
[TBL] [Abstract][Full Text] [Related]
28. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.
Puel A; Cypowyj S; Maródi L; Abel L; Picard C; Casanova JL
Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):616-22. PubMed ID: 23026768
[TBL] [Abstract][Full Text] [Related]
29. Immunology. An innate role for IL-17.
Dominguez-Villar M; Hafler DA
Science; 2011 Apr; 332(6025):47-8. PubMed ID: 21454778
[No Abstract] [Full Text] [Related]
30. New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe.
Soltész B; Tóth B; Shabashova N; Bondarenko A; Okada S; Cypowyj S; Abhyankar A; Csorba G; Taskó S; Sarkadi AK; Méhes L; Rozsíval P; Neumann D; Chernyshova L; Tulassay Z; Puel A; Casanova JL; Sediva A; Litzman J; Maródi L
J Med Genet; 2013 Sep; 50(9):567-78. PubMed ID: 23709754
[TBL] [Abstract][Full Text] [Related]
31. Biological and clinical significance of T helper 17 cell deficiency: insight into monogenic defects.
Anka AU; Abdullahi IN; Umar K; Bello ZM; Mohammed M; Gachpaz Sarkhiz S; Abubakar NK; Alsabbagh M; Kamali AN; Azizi G
Eur Ann Allergy Clin Immunol; 2021 Jul; 53(4):149-160. PubMed ID: 32549544
[TBL] [Abstract][Full Text] [Related]
32. Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain.
Takezaki S; Yamada M; Kato M; Park MJ; Maruyama K; Yamazaki Y; Chida N; Ohara O; Kobayashi I; Ariga T
J Immunol; 2012 Aug; 189(3):1521-6. PubMed ID: 22730530
[TBL] [Abstract][Full Text] [Related]
33. [Chronic mucocutaneous candidiasis with STAT1 gain-of-function mutation associated with herpes virus and mycobacterial infections].
Baghad B; Benhsaien I; El Fatoiki FZ; Migaud M; Puel A; Chiheb S; Bousfiha AA; Ailal F
Ann Dermatol Venereol; 2020 Jan; 147(1):41-45. PubMed ID: 31677808
[TBL] [Abstract][Full Text] [Related]
34. Skin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses.
Smeekens SP; Huttenhower C; Riza A; van de Veerdonk FL; Zeeuwen PL; Schalkwijk J; van der Meer JW; Xavier RJ; Netea MG; Gevers D
J Innate Immun; 2014; 6(3):253-62. PubMed ID: 23796786
[TBL] [Abstract][Full Text] [Related]
35. Orf Infection in a Patient with Stat1 Gain-of-Function.
Kilic SS; Puel A; Casanova JL
J Clin Immunol; 2015 Jan; 35(1):80-3. PubMed ID: 25367169
[TBL] [Abstract][Full Text] [Related]
36. Case Report: Disseminated
Chen K; Tan J; Qian S; Wu S; Chen Q
Front Immunol; 2021; 12():682350. PubMed ID: 34421897
[TBL] [Abstract][Full Text] [Related]
37. Recurrent inflammatory aortic aneurysms in chronic mucocutaneous candidiasis with a gain-of-function STAT1 mutation.
Tanimura M; Dohi K; Hirayama M; Sato Y; Sugiura E; Nakajima H; Kanemitsu S; Toyoda H; Yamada N; Masuya M; Imanaka-Yoshida K; Shimpo H; Azuma E; Ito M
Int J Cardiol; 2015 Oct; 196():88-90. PubMed ID: 26080282
[No Abstract] [Full Text] [Related]
38. Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation.
Weinacht KG; Charbonnier LM; Alroqi F; Plant A; Qiao Q; Wu H; Ma C; Torgerson TR; Rosenzweig SD; Fleisher TA; Notarangelo LD; Hanson IC; Forbes LR; Chatila TA
J Allergy Clin Immunol; 2017 May; 139(5):1629-1640.e2. PubMed ID: 28139313
[TBL] [Abstract][Full Text] [Related]
39. A gain-of-function mutation of STAT1: A novel genetic factor contributing to chronic mucocutaneous candidiasis.
Eslami N; Tavakol M; Mesdaghi M; Gharegozlou M; Casanova JL; Puel A; Okada S; Arshi S; Bemanian MH; Fallahpour M; Molatefi R; Seif F; Zoghi S; Rezaei N; Nabavi M
Acta Microbiol Immunol Hung; 2017 Jun; 64(2):191-201. PubMed ID: 28597685
[TBL] [Abstract][Full Text] [Related]
40. Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?
Puel A; Picard C; Cypowyj S; Lilic D; Abel L; Casanova JL
Curr Opin Immunol; 2010 Aug; 22(4):467-74. PubMed ID: 20674321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
